Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-62471
Senti, Gabriela; Crameri, Reto; Kuster, Daniela; Johansen, Pål; Martinez-Gomez, Julia M; Graf, Nicole; Steiner, Martin; Hothorn, Ludwig A; Grönlund, Hans; Tivig, Christine; Zaleska, Anna; Soyer, Ozge; van Hage, Marianne; Akdis, Cezmi A; Akdis, Mübeccel; Rose, Horst; Kündig, Thomas M (2012). Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections. Journal of Allergy and Clinical Immunology, 129(5):1290-1296.
PDF - Registered users only
View at publisher
Background: Subcutaneous allergen-specific immunotherapy frequently causes allergic side effects and requires 30 to 80 injections over 3 to 5 years.
Objective: We sought to improve immunotherapy by using intralymphatic allergen administration (intralymphatic immunotherapy [ILIT]) and by targeting allergen to the MHC class II pathway.
Methods: Recombinant major cat dander allergen Fel d 1 was fused to a translocation sequence (TAT) and to part of the human invariant chain, generating a modular antigen transporter (MAT) vaccine (MAT–Fel d 1). In a randomized double-blind trial ILIT with MAT–Fel d 1 in alum was compared with ILIT with placebo (saline in alum) in allergic patients (ClinicalTrials.gov NCT00718679).
Results: ILIT with MAT–Fel d 1 elicited no adverse events. After 3 placebo injections within 2 months, nasal tolerance increased less than 3-fold, whereas 3 intralymphatic injections with MAT–Fel d 1 increased nasal tolerance 74-fold (P < .001 vs placebo). ILIT with MAT–Fel d 1 stimulated regulatory T-cell responses (P = .026 vs placebo) and increased cat dander–specific IgG4 levels by 5.66-fold (P = .003). The IgG4 response positively correlated with IL-10 production (P < .001).
Conclusion: In a first-in-human clinical study ILIT with MAT–Fel d 1 was safe and induced allergen tolerance after 3 injections.
0 downloads since deposited on 24 May 2012
0 downloads since 12 months
|Item Type:||Journal Article, refereed, original work|
|Communities & Collections:||04 Faculty of Medicine > Swiss Institute of Allergy and Asthma Research
04 Faculty of Medicine > University Hospital Zurich > Dermatology Clinic
|DDC:||610 Medicine & health|
|Deposited On:||24 May 2012 08:04|
|Last Modified:||14 Jan 2014 14:05|
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page